SCHEMBL8931032

SCHEMBL8931032

CCc1cc(-c2n[nH]c(=S)n2-c2cccc(OC)c2)c(O)cc1O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRNE Q04844 1/20 0.53
TDP1 Q9NUW8 1/20 0.52
HSP90AA1 P07900 1/20 0.51
HSP90AB1 P08238 1/20 0.51
KDM4E B2RXH2 6/20 0.50
ALDH1A1 P00352 4/20 0.50
KMT2A Q03164 3/20 0.50
MEN1 O00255 2/20 0.50
HTT P42858 1/20 0.50
GAA P10253 4/20 0.48
APOBEC3G Q9HC16 2/20 0.48
HSD17B10 Q99714 3/20 0.48
GFER P55789 3/20 0.48
L3MBTL1 Q9Y468 2/20 0.48
MAPT P10636 1/20 0.47
HPGD P15428 3/20 0.47
SMN1; SMN2 Q16637 3/20 0.47
LMNA P02545 1/20 0.47
PRNP P04156 1/20 0.47
PPARG P37231 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12045808 0.88 CYP1A2 (0.60) HSP90AA1HSP90AB1KMT2AMEN1GAA
SCHEMBL15759946 0.88 HPGD (0.58) TDP1HSP90AA1HSP90AB1KDM4EALDH1A1
SCHEMBL8931035 0.87 CYP1A2 (0.47) CHRNETDP1HSP90AA1KDM4EALDH1A1
SCHEMBL12046258 0.86 HSP90AA1 (0.54) TDP1HSP90AA1HSP90AB1KDM4EALDH1A1
SCHEMBL12046385 0.85 HSP90AA1 (0.51) TDP1HSP90AA1HSP90AB1KDM4EALDH1A1
SCHEMBL12046215 0.84 HSP90AA1 (0.50) TDP1HSP90AA1HSP90AB1KDM4EALDH1A1
SCHEMBL8930795 0.83 HSP90AA1 (0.57) TDP1HSP90AA1HSP90AB1KDM4EALDH1A1
SCHEMBL12046220 0.83 HSP90AA1 (0.49) TDP1HSP90AA1HSP90AB1KDM4EALDH1A1
SCHEMBL8930405 0.82 KDM4E (0.69) CHRNETDP1HSP90AA1HSP90AB1KDM4E
SCHEMBL13983500 0.82 HSP90AA1 (0.47) TDP1HSP90AA1HSP90AB1KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8188075-B2 Triazole compounds that modulate HSP90 activity SYNTA PHARMACEUTICALS CORP. (US) 2012-05-29 US disclosed
US-8188075-B2 Triazole compounds that modulate HSP90 activity SYNTA PHARMACEUTICALS CORP. (US) 2012-05-29 US disclosed
US-20100093717-A1 TRIAZOLE COMPOUNDS THAT MODULATE HSP90 ACTIVITY SYNTA PHARMACEUTICALS CORP 2010-04-15 US disclosed
US-20100093717-A1 TRIAZOLE COMPOUNDS THAT MODULATE HSP90 ACTIVITY SYNTA PHARMACEUTICALS CORP 2010-04-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100093717-A1 TRIAZOLE COMPOUNDS THAT MODULATE HSP90 ACTIVITY HSP90AB1, HSP90AA1, HSP90AB2P CHRNE 4850/4885TDP1 1766/4885HSP90AA1 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.